Identification of collateral lethal targets in prostate cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2110766
Recipient
Awarding agency
Obligated
$1,214,999

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Texas MD Anderson Cancer Center was awarded a $1,214,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify collateral lethal targets in prostate cancer from September 1, 2021 through August 31, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and cancer research. This award will advance those goals by supporting MD Anderson Cancer Center's work to discover new treatment targets for prostate cancer over the three-year period.

Quick answers

Who received award W81XWH2110766?

W81XWH2110766 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on September 1, 2021.

How much is award W81XWH2110766 worth?

$1,214,999 has been obligated on W81XWH2110766.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login